The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -57,685 |
| Depreciation and amortization | 78,261 |
| Amortization of deferred financing costs and mortgage discounts (premiums) | 4,753 |
| Accretion of terminated swap | -344 |
| Amortization (accretion) of market lease and other intangibles, net | 1,891 |
| Stock-based compensation amortization expense | 3,766 |
| Loss (gain) on non-designated derivative instruments | -72 |
| Cash received from non-designated derivative instruments | 3,292 |
| (gain) loss on sale of real estate investments | 27,800 |
| Gain on extinguishment of debt | 257 |
| Impairment charges | 44,914 |
| Deferred tax valuation allowance | -1,711 |
| Straight-line rent receivable, net | -1,355 |
| Prepaid expenses and other assets, net | -3,692 |
| Accounts receivable, net | 3,399 |
| Deferred leasing costs | 8,081 |
| Accounts payable, accrued expenses and other liabilities | -41,220 |
| Deferred rent | 2,030 |
| Net cash provided by (used in) operating activities | 6,951 |
| Acquisitions of real estate | 250 |
| Capital expenditures | 28,726 |
| Investments in non-designated interest rate caps, net | 1,379 |
| Proceeds from sales of real estate, net | 100,161 |
| Net cash provided by (used in) investing activities | 69,806 |
| Borrowings/proceeds from credit facility-Credit Agreement | 336,000 |
| Borrowings/proceeds from credit facility-Fannie Mae Secured Debt | 0 |
| Repayments of fannie mae and other secured debt | 27,476 |
| Proceeds from mortgage notes payable | 0 |
| Repayments of mortgage notes payable | 331,113 |
| Proceeds from interest rate swap terminations | 8,259 |
| Payments of deferred financing costs | 6,211 |
| Proceeds from promissory note | 0 |
| Taxes paid for net settlement of equity-based awards | 612 |
| Payment of offering costs | 1,217 |
| Dividend paid on preferred stock-Series ACumulative Redeemable Perpetual Preferred Stock | 7,181 |
| Dividend paid on preferred stock-Series BCumulative Redeemable Perpetual Preferred Stock | 6,264 |
| Repurchase of preferred stock | 5,423 |
| Purchase of non-controlling interest | 978 |
| Contributions from non-controlling interest holders | 0 |
| Distributions to non-controlling interest holders | 184 |
| Net cash (used in) provided by financing activities | -42,400 |
| Net change in cash, cash equivalents and restricted cash | 34,357 |
National Healthcare Properties, Inc. (HLTC)
National Healthcare Properties, Inc. (HLTC)